Teleurology: The time has arrived
This article will discuss obstacles that urologists typically must address when implementing telemedicine into their practice.
Related Articles
Radium-223 re-treatment is safe in patients with mCRPC
The median number of re-injections was 6 (range, 1-12).
Amar Kishan, MD, highlights ongoing research on reducing toxicity in SBRT
“For the MIRAGE trial specifically, we’re going to continue following patients and we’ll look at [data at] 5 years as well,” says Amar U. Kishan,…
UGN-101 associated with favorable long-term durability in low-grade UTUC
The median duration of response was 47.8 months among patients who achieved an initial complete response.
Investigators explore social vulnerability and urinary incontinence
“I think targeting things that make communities more vulnerable would be reasonable things to target to try and affect disease practices,” says William Furuyama, MD.
Experts consider efficacy of fertility restoration vs sperm cryopreservation
“While I would hesitate to say that reversal is truly better in terms of efficacy, I think this data suggests that it’s at least as…
Danish Medicines Agency approves PSMA-PET imaging product for prostate cancer
Illuccix has been previously approved in the US, Australia, Canada, and Europe.
Survey data highlights substantial impact of postpartum incontinence
Overall, 85% of respondents indicating that they experienced frequent bladder leaks.
Navigating Therapies for BCG-Unresponsive NMIBC: Immunotherapies and Chemotherapies
Experts discuss the evolving landscape of chemotherapy and immunotherapy options for patients with non-muscle invasive bladder cancer (NMIBC).
Dayna R. Smerina and Amy M. Pearlman, MD, discuss their research in sexual medicine
Smerina and Pearlman discuss recent research collaborations in the field of sexual medicine.
Biomarkers in advanced prostate cancer: Liquid biopsy, ctDNA, and more
“The management of advanced prostate cancer has evolved significantly, driven in part by the integration of diverse biomarkers that guide treatment decisions from diagnosis through…